| scholarly article | Q13442814 |
| P2093 | author name string | Mahavir Singh | |
| Peter Hart | |||
| Simon M Cutting | |||
| Rajko Reljic | |||
| Mathew J Paul | |||
| Gil R Diogo | |||
| Alastair Copland | |||
| Shane Harris | |||
| Andy C Tran | |||
| P2860 | cites work | Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides | Q24303817 |
| The Immunodominant T-Cell Epitopes of the Mycolyl-Transferases of the Antigen 85 Complex of M. tuberculosis | Q26852552 | ||
| Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization | Q27321593 | ||
| Antibodies and tuberculosis | Q28067735 | ||
| Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? | Q28083377 | ||
| A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data | Q28383049 | ||
| Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis | Q28478015 | ||
| In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens | Q29615098 | ||
| New use of BCG for recombinant vaccines | Q29615313 | ||
| Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial | Q29620144 | ||
| Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies | Q30430925 | ||
| Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. | Q30870101 | ||
| Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. | Q33619034 | ||
| Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. | Q33791961 | ||
| A novel human IgA monoclonal antibody protects against tuberculosis | Q33800841 | ||
| Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo | Q33921252 | ||
| Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes | Q34300368 | ||
| Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis. | Q34464971 | ||
| Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. | Q34491796 | ||
| Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity | Q34491896 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| Bacillus subtilis isolated from the human gastrointestinal tract | Q34899449 | ||
| Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
| Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction | Q35709003 | ||
| Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine | Q35886473 | ||
| Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis. | Q36208249 | ||
| Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection | Q36305994 | ||
| PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin | Q56899239 | ||
| Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells | Q57227696 | ||
| MHC Class II Expression Is Regulated in Dendritic Cells Independently of Invariant Chain Degradation | Q58758033 | ||
| Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses | Q79401087 | ||
| IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice | Q79784864 | ||
| CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization | Q84592546 | ||
| Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model | Q88208444 | ||
| Synovial Regulatory T Cells Occupy a Discrete TCR Niche in Human Arthritis and Require Local Signals To Stabilize FOXP3 Protein Expression | Q36350402 | ||
| Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells. | Q36463118 | ||
| The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine | Q36497412 | ||
| Biological safety concepts of genetically modified live bacterial vaccines | Q36713988 | ||
| CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease | Q36951532 | ||
| Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection | Q37121948 | ||
| Mucosal vaccination against tuberculosis using inert bioparticles | Q37264883 | ||
| Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis. | Q37430524 | ||
| Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. | Q37521363 | ||
| Molecular signatures of antibody responses derived from a systems biology study of five human vaccines | Q37625332 | ||
| Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens. | Q37713305 | ||
| Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials | Q38171263 | ||
| Bacillus subtilis spores as adjuvants for DNA vaccines | Q38893653 | ||
| A Functional Role for Antibodies in Tuberculosis | Q39352413 | ||
| Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity | Q40062912 | ||
| Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis | Q40171033 | ||
| Bacillus subtilis spores: a novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen | Q40217103 | ||
| Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo | Q40316247 | ||
| Exopolysaccharide from Bacillus subtilis Induces Anti-Inflammatory M2 Macrophages That Prevent T Cell-Mediated Disease | Q40331504 | ||
| Systems analysis of protective immune responses to RTS,S malaria vaccination in humans | Q40334346 | ||
| The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. | Q40793082 | ||
| Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered | Q41884107 | ||
| Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation | Q42090368 | ||
| Hydrophobicity of Bacillus and Clostridium spores. | Q42125691 | ||
| Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara | Q45722508 | ||
| What We Know About Tuberculosis Transmission: An Overview | Q46587049 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Bacillus subtilis | Q131238 |
| P304 | page(s) | 346 | |
| P577 | publication date | 2018-03-12 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin. | |
| P478 | volume | 9 |
| Q89866252 | Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells |
| Q64059740 | Bacillus Calmette-Guérin Induces PD-L1 Expression on Antigen-Presenting Cells via Autocrine and Paracrine Interleukin-STAT3 Circuits |
| Q90129580 | Comparison of eight Lactobacillus species for delivery of surface-displayed mycobacterial antigen |
| Q90004714 | Emerging Themes for the Role of Antibodies in Tuberculosis |
| Q92239476 | Inactivated Lactobacillus plantarum Carrying a Surface-Displayed Ag85B-ESAT-6 Fusion Antigen as a Booster Vaccine Against Mycobacterium tuberculosis Infection |
| Q64067951 | Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis |
| Q56359630 | Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man |
| Q59332933 | Mouse intestinal microbiota reduction favors local intestinal immunity triggered by antigens displayed in Bacillus subtilis biofilm |
| Q92246549 | Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges |
Search more.